Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating

Hyperhidrosis Clinical Trial

Official title:

Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00509886
• Other study ID #: STU00000722
• Status: Completed
• Phase: N/A
• First received: July 31, 2007
• Last updated: November 7, 2014
• Start date: June 2007
• Est. completion date: August 2007

Study information

• Verified date: November 2014
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.

Description:

The objective of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: August 2007
• Est. primary completion date: August 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 21 Years to 30 Years

Eligibility

Inclusion Criteria:

• age 21-30 years

• males and females

• The subjects are in good health.

• The subjects have willingness and the ability to understand and provide informed consent for participation in the study.

Exclusion Criteria:

• Subjects with primary hyperhidrosis

• Subjects who are unable to withstand prolonged heat exposure or who have self-reported history of cardiovascular or respiratory disorders.

• Subjects who are unable to give informed consent.

• Subjects with mental illness.

• Subjects who are pregnant or nursing.

• Subjects with systemic or local skin disease and/or infection that may interfere with the conduct of the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Excess Sweating
• Hyperhidrosis

Intervention

Drug:
• Drysol
20% aluminum chloride hexahydrate
• Drioff
1% aluminum acetate

Locations

Country	Name	City	State
United States	Northwestern University Dermatology	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gravimetric analysis		3 hours	No
Secondary	Subject sweat assessment		3 hours	No
Secondary	HDSS		3 hours	No